NDC 25021-471 – fulvestrant

Fulvestrant 50 mg/mL · Injection, Solution · Intramuscular

Human Prescription Drug

Product NDC25021-471

Product details

Brand name
fulvestrant
Generic name
fulvestrant
Labeler
Sagent Pharmaceuticals
Dosage form
Injection, Solution
Route
Intramuscular
Marketing category
ANDA · ANDA211422
Marketed since
April 15, 2026
Listing expires
December 31, 2027
Pharmacologic class
Estrogen Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Fulvestrant →

Package NDC codes (2)

Package NDCDescriptionSince
25021-471-662 SYRINGE in 1 CARTON (25021-471-66) / 5 mL in 1 SYRINGEApr 15, 2026
25021-471-742 SYRINGE in 1 CARTON (25021-471-74) / 5 mL in 1 SYRINGESep 15, 2024

Other Fulvestrant products